Seretide 125

Poland
Brand name Seretide 125
Form aerosol, inhalation suspension
Active substance / Dosage
Prescription type Prescription only
ATC code
Registration number 100104995
Seretide 125 aerosol, inhalation suspension

Patient Information Leaflet

Seretide 50, (50 μg + 25 μg)/metered dose, inhalation aerosol, suspension
Seretide 125, (125 μg + 25 μg)/metered dose, inhalation aerosol, suspension
Seretide 250, (250 μg + 25 μg)/metered dose, inhalation aerosol, suspension
Fluticasone propionate + Salmeterol
Please read this leaflet carefully before using this medicine, as it contains
important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any further questions, please ask your doctor or pharmacist.
  • This medicine has been prescribed for a specific individual. Do not pass it on to others. It may harm someone else even if their symptoms are the same.
  • If you experience any adverse reactions, including any not listed in this leaflet, inform your doctor or pharmacist. See section 4.

Leaflet contents:

  1. What Seretide is and what it is used for
  2. Important information before using Seretide
  3. How to use Seretide
  4. Possible side effects
  5. How to store Seretide
  6. Contents of the pack and other information

1. What Seretide is and what it is used for

Seretide contains two active substances: salmeterol and fluticasone propionate.

  • Salmeterol is a long-acting bronchodilator. Bronchodilators help keep the airways open, making it easier for air to flow into and out of the lungs. Its effect lasts for at least 12 hours.
  • Fluticasone propionate is a corticosteroid that reduces swelling and irritation in the lungs.

Your doctor has prescribed this medicine to prevent breathing difficulties associated with asthma.
To ensure proper asthma control, Seretide must be used every day as directed by your doctor.
Seretide helps prevent episodes of breathlessness and wheezing. However, it should not be used
to relieve sudden attacks of breathlessness or wheezing. If such an attack occurs, a fast-acting
bronchodilator, such as salbutamol, should be used immediately. You should always have this
medicine readily available.

2. Important information before using Seretide

When not to use Seretide

  • if the patient is allergic to salmeterol, fluticasone propionate, or to norflurane (HFA 134a), an excipient of the medicine.

Warnings and precautions
Talk to your doctor before starting treatment with Seretide if the patient has:

  • heart disease, including irregular or rapid heartbeat,
  • hyperthyroidism,
  • high blood pressure,
  • diabetes (Seretide may increase blood glucose levels),
  • low potassium levels in the blood,
  • active or previously treated tuberculosis, or other lung infections.

If the patient experiences blurred vision or other visual disturbances, they should contact their doctor.
Seretide and other medicines
Tell your doctor about all medicines the patient is currently taking, has recently taken, or plans to take, including asthma medications and over-the-counter medicines. Seretide should not be used with certain medicines. Before starting Seretide, inform your doctor if the patient is taking any of the following medicines:

  • Medicines from the class of β-blockers (e.g. atenolol, propranolol, and sotalol). β-blockers are commonly used in the treatment of high blood pressure or other heart conditions.
  • Medicines used to treat infections (e.g. ketoconazole, itraconazole, and erythromycin), including certain medicines used to treat HIV (e.g. ritonavir, drugs containing cobicistat). Some of these medicines may increase the levels of fluticasone propionate or salmeterol in the body. This may increase the risk of adverse effects, including irregular heartbeat, or may worsen existing side effects. Your doctor may wish to closely monitor the patient's condition while taking such medicines.
  • Corticosteroids (taken orally or by injection). If the patient has recently taken such medicines, this may increase the risk of adrenal dysfunction.
  • Diuretics used in the treatment of high blood pressure.
  • Other bronchodilators (such as salbutamol).
  • Medicines containing xanthine derivatives, commonly used in the treatment of asthma.

Pregnancy and breastfeeding
If the patient is pregnant, breastfeeding, suspects she may be pregnant, or is planning to have a baby, she should consult her doctor before using this medicine. The doctor will decide whether the patient can take Seretide during this period.
Driving and operating machinery
It is unlikely that Seretide will affect the ability to drive or operate machinery.

3. How to use Seretide

Seretide should always be used exactly as your doctor has instructed. If you are unsure,
you should consult your doctor or pharmacist.

  • Seretide should be used every day until your doctor advises otherwise. Do not take a higher dose than recommended. If in doubt, consult your doctor or pharmacist.
  • Do not stop using Seretide or reduce the dose without first consulting your doctor.
  • Seretide should be inhaled into the lungs through the mouth.

Adults and adolescents aged 12 years and older:

  • Seretide 50: two inhalations twice daily.
  • Seretide 125: two inhalations twice daily.
  • Seretide 250: two inhalations twice daily.

Children aged 4 to 12 years:

  • Seretide 50: two inhalations twice daily.
  • Seretide is not recommended for use in children under 4 years of age.

If asthma symptoms are well controlled while using Seretide twice daily,
your doctor may recommend reducing the frequency of Seretide to once daily.
The dose may be taken:

  • once daily in the evening, if the patient's symptoms occur at night,
  • once daily in the morning, if the patient's symptoms occur during the day.

It is very important that your doctor instructs you on how many inhalations to take and how often.
If you are using Seretide for asthma, your doctor will regularly monitor your symptoms.
If asthma symptoms worsen or asthma control deteriorates, you should
contact your doctor immediately. There may be an increase in wheezing, more frequent
chest tightness, or you may need to use a higher dose of a fast-acting, inhaled medicine to help
breathe. In such a case, continue using Seretide, but do not increase the number of inhalations.
Your symptoms may worsen and your condition may deteriorate. Contact your doctor, as you may
require additional treatment.
Instructions for using the inhaler

  • Your doctor, nurse, or pharmacist should instruct you on how to use the inhaler correctly. They should periodically check that you are using the inhaler properly. Incorrect use of Seretide or improper use of the inhaler may result in the medicine not providing the expected improvement in asthma.
  • The medicine is contained in a pressurized canister within a plastic casing with a mouthpiece.
  • On the back of the inhaler is a dose counter showing how many doses of medicine remain in the inhaler. Each time the canister is pressed, a dose of medicine is released and the counter decreases by one.
  • Be careful not to drop the inhaler, as this may cause the counter to decrease.

Checking the inhaler

  1. Before first use, check that the inhaler is working. Remove the mouthpiece cap by gently pressing the sides of the cap with your thumb and index finger.
Hands separating and connecting two parts of the inhaler, with an arrow indicating the direction of attaching the upper part to the lower housing of the device
  1. To ensure the inhaler is working, shake it vigorously, point the mouthpiece away from you, and release a dose into the air; repeat this, shaking the inhaler immediately before releasing each dose, until the counter reads 120. If the inhaler has not been used for a week or longer, remove the mouthpiece cap, shake the inhaler vigorously, and release two doses into the air.

Using the inhaler
It is important to begin breathing slowly and as steadily as possible even before
using the inhaler.

  1. Use the inhaler while standing or sitting.
  2. Remove the mouthpiece cap from the inhaler (as shown in Figure 1). Check the mouthpiece inside and out to ensure it is clean and free of foreign objects.
  3. Shake the inhaler 4 or 5 times to remove any foreign particles and to ensure the contents are evenly mixed.
Hand holding an MDI-type inhaler, with a black arrow indicating the rotational movement of the device in the user's hand
  1. Hold the inhaler upright with your fingers, placing your thumb on the base of the inhaler, below the mouthpiece. Breathe out as deeply as possible.
A woman holds the inhaler to her mouth, with black arrows showing the direction of drug release toward her open mouth and nose
  1. Place the mouthpiece in your mouth and seal your lips tightly around it. Do not bite the mouthpiece.
A woman holds the inhaler to her mouth, preparing to take a dose of medication, close-up of face and hand in black-and-white lighting
  1. Begin a slow and deep inhalation. Immediately after starting to inhale through your mouth, press down on the inhaler to release a dose of Seretide, then continue a steady, deep inhalation.
A woman holds a small cup to her mouth with both hands, drinking liquid from the container, with a black arrow pointing downward at the cup
  1. Hold your breath, remove the inhaler from your mouth, and lift your finger from the canister. Hold your breath for a few seconds, or as long as is comfortable, then breathe out slowly.
A close-up of a woman holding an inhaler vertically in her hand, carefully examining the medical device against a light background
  1. If your doctor has prescribed two inhalations, wait approximately half a minute before repeating steps 3–7.
  2. Rinsing your mouth with water and spitting it out and/or brushing your teeth after inhalation helps prevent hoarseness and oral thrush.
  3. After inhalation, always replace the mouthpiece cap to prevent dust from entering. Push the cap into place firmly. If you do not hear a click when replacing the cap, remove it, turn it around, and try again. Do not use excessive force.

Do not rush through steps 4, 5, 6, and 7. It is important to breathe as slowly as possible
immediately before inhalation. To ensure the inhalation is performed correctly, it is advisable to
initially practice using the inhaler in front of a mirror. Any "mist" escaping from the inhaler,
mouth, or nose during inhalation indicates incorrect inhalation technique. Repeat the steps
starting from step 3.
As with all inhalers, caregivers should ensure that children prescribed Seretide use the inhaler
correctly, as described above.
If you have difficulty coordinating your breath with inhalation from the inhaler, your doctor may
recommend using the inhaler with a spacer device. Your doctor, nurse, or pharmacist should
instruct you on how to use the inhaler correctly with a spacer, how to care for the spacer, and
answer any related questions. If you use a spacer, it is important not to stop using it without
consulting your doctor or nurse. It is also important not to change the type of spacer without
consulting your doctor. If you stop using a spacer or change to a different type, your doctor may
decide to adjust the dose of medicine needed to control asthma symptoms. Always consult your
doctor before making any changes to your asthma treatment.
Older children or people with weak hands may find it easier to hold the inhaler with both hands.
Hold the inhaler with both index fingers on top and both thumbs underneath, below the mouthpiece.
When the counter reads 020, remember that you are approaching the time to replace your inhaler.
Replace the inhaler when the counter reads 000, as the remaining medicine may be insufficient for
a full dose. Never attempt to increase the counter reading, as it cannot be reset.
Cleaning the inhaler
To prevent blockage, clean the inhaler at least once a week.
To clean the inhaler:

  • Remove the mouthpiece cap.
  • Do not remove the metal canister from the plastic casing during cleaning or at any other time.
  • Wipe the mouthpiece inside and out and the outside of the plastic casing with a dry cloth or tissue.
  • Replace the mouthpiece cap. When properly replaced, you should hear a click. If you do not hear a click, remove the cap, turn it around, and try again. Do not use excessive force.

Do not immerse the metal canister in water.
Using more Seretide than recommended
It is important to use the inhaler as instructed. If you accidentally use more than the recommended
dose, inform your doctor or pharmacist.
Symptoms may include: faster than normal heartbeat, tremors, dizziness, headache, muscle weakness,
and joint pain.
If higher doses have been used for a prolonged period, contact your doctor or pharmacist for advice,
as high doses of Seretide may reduce the adrenal glands' production of steroid hormones.
Missing a dose of Seretide
Do not take a double dose to make up for a missed dose. Take the next dose at the scheduled time.
Stopping Seretide
It is very important to take Seretide every day as prescribed. You should continue taking the
medicine until your doctor advises you to stop. Do not suddenly stop taking Seretide or reduce
the dose, as your symptoms may worsen.
Additionally, abruptly stopping or reducing the dose of Seretide may (very rarely) lead to adrenal
gland dysfunction (adrenal insufficiency), which may sometimes cause adverse effects.
These adverse effects may include any of the following:

  • abdominal pain,
  • fatigue and loss of appetite, nausea,
  • vomiting and diarrhoea,
  • weight loss,
  • headache and drowsiness,
  • low blood sugar,
  • low blood pressure and seizures. During periods of stress caused by fever, injury (such as a car accident), infection, or surgery, adrenal insufficiency may worsen and any of the adverse effects listed above may occur.

If you experience any of these adverse effects, inform your doctor or pharmacist.
To prevent these symptoms, your doctor may prescribe additional corticosteroids in tablet form (e.g. prednisolone).
If you have any further questions about the use of this medicine, consult your doctor, nurse, or pharmacist.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone will experience them.
To reduce the risk of adverse effects, your doctor will prescribe the lowest dose of
Seretide that provides control of asthma.
Allergic reactions: The patient may experience sudden breathing difficulties immediately
after using Seretide. Worsening of wheezing, cough, or shortness of breath may occur, as well as itching, rash (urticaria), and swelling (usually of the face, lips, tongue, or throat). A sensation of very rapid heartbeat, weakness, or dizziness (which may lead to collapse or loss of consciousness) may also occur. If any of these symptoms occur suddenly after using Seretide, stop using Seretide immediately and contact your doctor without delay. Allergic reactions to Seretide occur uncommonly (may occur in 1 to 10 out of 1,000 patients taking the medicine).
Other adverse effects:
Very common adverse effects (may affect more than 1 in 10 patients):

  • Headache – this adverse effect usually decreases over time with continued treatment.
  • Increased incidence of colds has been reported in patients with COPD.

Common adverse effects (may affect 1 to 10 in 100 patients):

  • Oral and pharyngeal candidiasis (painful, creamy-white lesions), as well as tongue pain, hoarseness, loss of voice, and throat irritation. Rinsing the mouth with water and spitting it out, and/or brushing teeth immediately after each inhalation may be helpful. Your doctor may prescribe an antifungal medicine to treat candidiasis.

  • Joint pain, joint swelling, and muscle pain.

  • Muscle cramps.

The following adverse effects have been reported in patients with chronic obstructive pulmonary disease (COPD):

  • Pneumonia (lung infection). Inform your doctor if any of the following symptoms occur during treatment with Seretide – they may be signs of lung infection: fever or chills, increased mucus production, change in mucus colour, worsening cough, or increased breathing difficulties.
  • Easy bruising and traumatic fractures.
  • Sinusitis (feeling of pressure and fullness in the nose, cheeks, and behind the eyes, sometimes with pulsating pain).
  • Decreased blood potassium levels (the patient may experience irregular heartbeat, muscle weakness, cramps).

Uncommon adverse effects (may affect 1 to 10 in 1,000 patients):

  • Increased blood sugar (glucose) levels (hyperglycaemia). In patients with diabetes, more frequent monitoring of blood glucose levels may be required, and the dose of currently used antidiabetic medicines may need to be adjusted.
  • Cataract (clouding of the eye lens).
  • Very rapid heartbeat (tachycardia).
  • Tremor and rapid or irregular heartbeat (palpitations) – these symptoms are usually not serious and tend to decrease with continued treatment.
  • Atrial fibrillation.
  • Ischaemic heart disease, characterised by chest pain or pressure, and shortness of breath.
  • Sleep disturbances.
  • Restlessness.
  • Allergic skin rash.

Rare adverse effects (may affect 1 to 10 in 10,000 patients):

  • Worsening of wheezing or breathing difficulties occurring immediately after taking Seretide. If such symptoms occur, stop using Seretide immediately, use a fast-acting inhaled medicine to relieve breathing difficulties, and contact your doctor immediately.
  • Seretide may interfere with the body's normal production of steroid hormones, particularly when high doses are used for prolonged periods. These effects include:
    • slowed growth in children and adolescents,
    • reduced bone mass,
    • glaucoma,
    • increased body weight,
    • rounding (moon-shaped) of the face (Cushing's syndrome). Your doctor will regularly check for these adverse effects and ensure that you are using the lowest dose of Seretide that controls asthma.
  • Behavioural changes such as excessive excitability and irritability (these effects occur mainly in children).
  • Irregular heartbeat or extra beats (arrhythmias). Inform your doctor, but do not stop using Seretide unless instructed by your doctor.
  • Fungal infection of the oesophagus, which may cause difficulty swallowing.

Adverse effects with unknown frequency (frequency cannot be estimated from available data):

  • Depression or aggression. These effects are more likely to occur in children.
  • Blurred vision.

Reporting of adverse effects
If any adverse effects occur, including those not listed in this leaflet, inform your doctor or pharmacist. Adverse effects can be reported directly to the Department of Monitoring Adverse Drug Reactions of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309, website: https://smz.ezdrowie.gov.pl
Adverse effects can also be reported to the marketing authorisation holder.
Reporting adverse effects helps to provide more information on the safety of this medicine.

5. How to store Seretide

  • Keep out of the sight and reach of children.
  • Do not use Seretide after the expiry date stated on the container. The expiry date (EXP) refers to the last day of the stated month. The Lot number indicates the batch number.
  • Store below 30°C. Do not refrigerate or freeze.
  • As with most pressurised inhalation medicines, the therapeutic effect of this medicine may be reduced if the container is cold.
  • The metal container holds a pressurised suspension. Do not expose to temperatures above 50°C and protect from direct sunlight. Do not pierce or burn the container, even if it appears to be empty. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

What Seretide contains

  • The active substances are: salmeterol and fluticasone propionate. Each metered dose contains 25 micrograms (µg) of salmeterol (as salmeterol xinafoate) and 50, 125, or 250 micrograms (µg) of fluticasone propionate.
  • The other component is a propellant gas: 1,1,1,2-tetrafluoroethane (norflurane, HFA 134a).

This medicine contains fluorinated greenhouse gases.
Each inhaler contains g, equivalent to
tonnes of CO₂ (global warming potential GWP = ).

What Seretide looks like and contents of the pack

  • Seretide is supplied in an inhaler containing a pressurized suspension for oral inhalation into the lungs.
  • The pressurized container contains a white to off-white suspension for inhalation.
  • Packaging: An aluminium container closed with a metering valve, fitted with a plastic actuator with a dose counter, in a cardboard box. One pressurized container contains 120 doses.

Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder: Manufacturer:
GlaxoSmithKline Trading Services Limited Glaxo Wellcome Production
12 Riverwalk Zone Industrielle No. 2
Citywest Business Campus 23, rue Lavoisier
Dublin 24 27000 Evreux
D24 YK11 France
Ireland
For further information, please contact the Marketing Authorisation Holder's representative:
GSK Services Sp. z o.o.
tel. (22) 576-90-00
{marketing authorisation holder's logo}